🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Science(2021)10.1126/science.abf4063Source: DataRank Database

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection is a research paper published in Science (2021). On theSindex it has a DataRank of 0. It has been cited 3,012 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3,012 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (28 grants)OA: hybridTopics (65)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

José Mateus ORCID,Yu Kato ORCID,Kathryn M. Hastie ORCID,Esther Dawen Yu ORCID,Caterina E. Faliti

Live enrichment

PubMed:33408181 PMC:PMC7919858

National Institutes of Health

Grant: Nr. 75N9301900065

National Institute of Allergy and Infectious Diseases

Grant: AI142742

National Institute of Allergy and Infectious Diseases

Grant: AI135078

National Institute of Allergy and Infectious Diseases

Grant: HHSN272201400008C

National Institute of Allergy and Infectious Diseases

Grant: 75N93019C00051

National Institute of Allergy and Infectious Diseases

Grant: AI007036

National Institute of Allergy and Infectious Diseases

Grant: U01 AI141995

Bill and Melinda Gates Foundation

Grant: INV-006133

National Institute of Allergy and Infectious Diseases

Grant: AI141995-03

National Institute of Allergy and Infectious Diseases

Grant: U01 CA260541-01

Open Philanthropy Project

Grant: 2020-215611

National Institute of Allergy and Infectious Diseases

Grant: AI007384

NIAID NIH HHS

Grant: T32 AI007036

NIAID NIH HHS

Grant: U19 AI142742

NCI NIH HHS

Grant: U01 CA260541

NIAID NIH HHS

Grant: T32 AI007384

NIAID NIH HHS

Grant: K08 AI135078

NIAID NIH HHS

Grant: R01 AI135193

National Institutes of Health

Grant: 5U01AI141995-05

Identifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping cough

National Institutes of Health

Grant: 5U19AI142742-03

Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses

National Institutes of Health

Grant: 2T32AI007384-06

AIDS TRAINING GRANT

National Institutes of Health

Grant: 1U01CA260541-01

SARS-CoV-2 correlates of protection in a Latino-origin population

National Institutes of Health

Grant: 5T32AI007036-19

RESEARCH IN INFECTIOUS DISEASES

National Institutes of Health

Grant: 5K08AI135078-02

The Immunology of Recurrent Group A Streptococcus Tonsillitis

Steven and Alexandra Cohen Foundation

JPB Foundation

John and Mary Tu Foundation

Wellcome Trust

hybridLicense: CC BY

publisherhttps://syndication.highwire.org/content/doi/10.1126/science.abf4063

publisherhttps://www.science.org/doi/pdf/10.1126/science.abf4063

Europe_PMChttps://europepmc.org/articles/PMC7919858

Europe_PMChttps://europepmc.org/articles/PMC7919858?pdf=render

https://doi.org/10.1126/science.abf4063

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

B-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHumansAntibodies, ViralLongitudinal StudiesCross-Sectional StudiesImmunologic MemoryAdultAgedAged, 80 and overMiddle AgedUnited StatesFemaleMaleYoung AdultAntibodies, NeutralizingSpike Glycoprotein, CoronavirusCOVID-19

Keywords

AdultCD4-Positive T-LymphocytesMale570CoronavirusesGeneral Science & TechnologyImmunology610CD8-Positive T-LymphocytesAntibodies, ViralAntibodiesVaccine RelatedYoung Adult80 and overHumansViralLongitudinal StudiesLungNeutralizingResearch ArticlesAgedAged, 80 and overB-LymphocytesMultidisciplinaryBiomedical and Clinical SciencesPreventionInflammatory and immune systemCOVID-19Middle AgedCoronaviruses Disparities and At-Risk PopulationsAntibodies, NeutralizingSpike GlycoproteinUnited StatesCoronavirusInfectious DiseasesEmerging Infectious DiseasesGood Health and Well BeingCross-Sectional StudiesSpike Glycoprotein, CoronavirusImmunizationFemaleInfectionImmunologic Memory

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (10)

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

N/A

1.4DataRank · unranked

Science(2020)

co-citedsame journal

10.1126/science.abb2507

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

N/A

1.1DataRank · unranked

Science(2020)

co-citedsame journal

10.1126/science.abd0826

SARS-CoV-2 infection protects against rechallenge in rhesus macaques

N/A

1.0DataRank · unranked

Science(2020)

co-citedsame journal

10.1126/science.abc4776

Structural basis of a shared antibody response to SARS-CoV-2

N/A

12.8DataRank · unranked

Science(2020)

co-citedsame journal

10.1126/science.abd2321

Broad neutralization of SARS-related viruses by human monoclonal antibodies

N/A

0.969DataRank · unranked

Science(2020)

co-citedsame journal

10.1126/science.abc7424

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

N/A

1.1DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2456-9

A serological assay to detect SARS-CoV-2 seroconversion in humans

N/A

1.1DataRank · unranked

Nature Medicine(2020)

co-cited

10.1038/s41591-020-0913-5

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

N/A

16.3DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2852-1

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

N/A

1.1DataRank · unranked

Cellular and Molecular Immunology(2020)

co-cited

10.1038/s41423-020-0400-4

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

N/A

13.6DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.06.025